Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Benzodiazepine Withdrawal Syndrome
IRCT20200701047979N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levetiracetam in benzodiazepine withdrawal syndrome (BWS), sponsored by Tehran University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
levetiracetam
03
Conditions
benzodiazepine withdrawal syndrome (BWS)
Beyond the preview
Go deeper on IRCT20200701047979N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200701047979N1.